13F-HR filed by MPM BIOIMPACT LLC
MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 44 holding rows worth $643,506,945.
- Accession
- 0000950123-24-008626
- Filer
- CIK 1687078
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 44 entries on the cover page, a total value of $643,506,945 stated on the cover page (in dollars after the unit check, H1), rows summing to $643,506,945 with VALUE read as dollars as filed, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 7,648,268 | $133,385,794 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 615,391 | $41,231,197 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 2,654,867 | $28,725,661 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 1,745,943 | $25,909,794 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 557,184 | $24,956,271 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 71,185 | $19,943,190 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 2,366,714 | $18,981,046 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 174,811 | $18,930,283 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 492,569 | $16,840,934 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 380,552 | $15,640,687 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 343,235 | $15,092,043 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 500,000 | $14,440,000 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 305,658 | $13,776,006 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 557,556 | $13,437,100 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 740,661 | $13,339,305 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 2,180,864 | $13,150,610 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 369,384 | $12,584,913 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 150,000 | $12,043,500 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 289,396 | $11,231,459 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 783,242 | $11,012,383 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 4,830,526 | $10,868,684 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 132,312 | $10,651,116 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 881,937 | $10,389,218 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 443,503 | $9,925,597 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 645,085 | $9,327,929 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 385,990 | $9,055,325 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 1,121,736 | $8,985,105 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,444,851 | $8,958,076 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 3,043,346 | $8,917,004 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 1,028,330 | $8,565,989 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,274,459 | $8,309,473 | dollars as filed | |
| CARTESIAN THERAPEUTICS INC | 816212302 | COMMON STOCK | 259,696 | $7,014,389 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 557,076 | $6,517,789 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 118,960 | $6,306,070 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,450,000 | $5,930,500 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 2,388,011 | $5,826,747 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 1,639,849 | $5,411,502 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 125,000 | $5,106,250 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 5,005,086 | $5,005,086 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 5,095,912 | $4,968,514 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 417,810 | $4,854,952 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,510,174 | $4,500,319 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 638,163 | $3,114,235 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 344,900 | $344,900 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-24-008626 | this filing | 2024-08-14 | acceptance time not in the bulk data set |